Atrial Shunting for Heart Failure

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Pharmacological therapies for heart failure (HF) have limitations in managing advanced stages.
• Symptomatic burden in advanced HF remains a significant unmet clinical need.
• Atrial shunting has emerged as a novel therapeutic approach for HF patients.

Purpose of the Study:

• To review the physiology, devices, and clinical trials shaping the field of atrial shunting.
• To explore the application of atrial shunting across the entire spectrum of HF.
• To detail different types of interatrial shunts and their potential clinical benefits and limitations.

Main Methods:

• Review of existing literature on atrial shunting in heart failure.
• Analysis of physiological principles underlying atrial shunt therapies.
• Examination of various device-based and no-implant interatrial shunt strategies.

Main Results:

• Atrial shunting is evolving from a therapy for diastolic HF to one applicable across the HF spectrum.
• Device-based interatrial shunts, no-implant shunts, and coronary sinus shunts are being investigated.
• These shunts aim to provide clinical benefit in specific HF patient populations.

Conclusions:

• Atrial shunting represents a promising novel therapy for symptomatic advanced heart failure.
• Understanding the physiology and device variations is crucial for optimizing patient selection.
• Further trials are needed to fully establish the efficacy and limitations of various atrial shunting techniques.